rCAST评分验证及其与PCAC和FOUR评分在院外心脏骤停后预后预测中的比较
该单中心回顾性研究纳入2014年1月至2022年8月收治的505例院外心脏骤停(OHCA)患者,计算rCAST、PCAC和FOUR评分预测出院时不良神经预后及院内死亡率的AUC并通过Delong检验比较。rCAST、PCAC、FOUR预测不良神经预后的AUC分别为0.815、0.753、0.841;预测死亡率的AUC分别为0.799、0.723、0.813。rCAST预测死亡率优于PCAC(p=0.017),FOUR预测不良神经预后(p<0.001)和死亡率(p<0.001)均优于PCAC。结论认为rCAST评分可可靠预测美国OHCA队列的不良预后,且不受TTM状态影响,优于PCAC评分。
要点
- rCAST评分预测出院不良神经预后的AUC为0.815(95%CI 0.763-0.867),预测院内死亡率的AUC为0.799(95%CI 0.751-0.847)。
- rCAST评分预测死亡率优于PCAC评分(p=0.017)。
- FOUR评分预测不良神经预后(p<0.001)和死亡率(p<0.001)均优于PCAC评分。
- rCAST评分可可靠预测美国OHCA患者不良预后,且不受TTM状态影响。
- 505例OHCA患者中,rCAST、PCAC、FOUR评分中位数[IQR]分别为9.5[6.0,11.5]、4[3,4]、2[0,5]。
适用人群与场景
- 2014年1月至2022年8月收治的院外心脏骤停(OHCA)患者,共505例具备全部三种评分数据。
研究设计与关键结果
- 单中心回顾性研究,纳入505例OHCA患者,rCAST、PCAC、FOUR评分中位数[IQR]分别为9.5[6.0,11.5]、4[3,4]、2[0,5]。
- 预测出院不良神经预后:rCAST的AUC为0.815(95%CI 0.763-0.867),PCAC为0.753(95%CI 0.697-0.809),FOUR为0.841(95%CI 0.796-0.886)。
- 预测院内死亡率:rCAST的AUC为0.799(95%CI 0.751-0.847),PCAC为0.723(95%CI 0.673-0.773),FOUR为0.813(95%CI 0.770-0.855)。
- rCAST评分预测死亡率优于PCAC评分(p=0.017)。
- FOUR评分预测不良神经预后(p<0.001)和死亡率(p<0.001)均优于PCAC评分。
证据类型、等级与局限
- 证据类型:单中心回顾性研究。
- 局限:原文未报告局限性。
对床旁实践的改变
- rCAST评分可可靠预测美国OHCA队列的不良预后,且不受TTM状态影响,并优于PCAC评分(作者结论)。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
AIM: Early, accurate outcome prediction after out-of-hospital cardiac arrest (OHCA) is critical for clinical decision-making and resource allocation. We sought to validate the revised post-Cardiac Arrest Syndrome for Therapeutic hypothermia (rCAST) score in a United States cohort and compare its prognostic performance to the Pittsburgh Cardiac Arrest Category (PCAC) and Full Outline of UnResponsiveness (FOUR) scores.
METHODS: This is a single-center, retrospective study of OHCA patients admitted between January 2014-August 2022. Area under the receiver operating curve (AUC) was computed for each score for predicting poor neurologic outcome at discharge and in-hospital mortality. We compared the scores' predictive abilities via Delong's test.
RESULTS: Of 505 OHCA patients with all scores available, the medians [IQR] for rCAST, PCAC, and FOUR scores were 9.5 [6.0, 11.5], 4 [3, 4], and 2 [0, 5], respectively. The AUC [95% confidence interval] of the rCAST, PCAC, and FOUR scores for predicting poor neurologic outcome were 0.815 [0.763-0.867], 0.753 [0.697-0.809], and 0.841 [0.796-0.886], respectively. The AUC [95% confidence interval] of the rCAST, PCAC, and FOUR scores for predicting mortality were 0.799 [0.751-0.847], 0.723 [0.673-0.773], and 0.813 [0.770-0.855], respectively. The rCAST score was superior to the PCAC score for predicting mortality (p = 0.017). The FOUR score was superior to the PCAC score for predicting poor neurological outcome (p < 0.001) and mortality (p < 0.001).
CONCLUSION: The rCAST score can reliably predict poor outcome in a United States cohort of OHCA patients regardless of TTM status and outperforms the PCAC score.
参考来源
- Kim N, Kitlen E, Garcia G, et al. Validation of the rCAST score and comparison to the PCAC and FOUR scores for prognostication after out-of-hospital cardiac arrest. Resuscitation. 2023. PMID: 37178901. doi:10.1016/j.resuscitation.2023.109832
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。